Auriga Reiterates a 'Buy' on MedAssets (MDAS); A Beat and Decent Guide Should Offset Negative Sentiment

August 2, 2011 7:14 AM EDT
Get Alerts MDAS Hot Sheet
Price: $31.35 --0%

Rating Summary:
    3 Buy, 20 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Auriga reiterates a 'Buy' on MedAssets (NASDAQ: MDAS) price target of $21.00.

Auriga analyst says, "We are reiterating our rating on MedAssets following strong Q2 results in which earnings handily exceeded EPS consensus while revenues edged out consensus. Importantly, the timing of two performance fees that were recognized one quarter early accounted for $2 million of revenue and approximately $0.02 of EPS. Spend Management also outperformed which contributed to the beat. In our view, MDAS' narrowed EPS range of $0.96-$1.02 on albeit a slightly weaker revenue guide is impressive enough to offset the tremendous negative sentiment heading into earnings. We find the stock very attractively valued and recommend purchase at current levels."

For more ratings news on MedAssets click here and for the rating history of MedAssets click here.

Shares of MedAssets closed at $12.00 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Auriga, Earnings